Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
(OP: LOBEF )
0.0126
+0.0015
(+13.51%)
Streaming Delayed Price
Updated: 1:13 PM EDT, Jun 20, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Mass-Scale Psilocin Clinical Supplies Are Ready For Upcoming Trials
October 14, 2022
Lobe Sciences Provides Company Review of 2023
January 08, 2024
Lobe Sciences Provides Update on L-130 Clinical Program
December 07, 2023
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
December 05, 2023
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
June 27, 2023
Trippy Trading: Top Psychedelic Stocks For 2023
January 17, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
||||||||||||||||||||
|